announced that it plans to launch its e-commerce platform for personalized natural health solutions this month. PanGenomic Health Inc. HP AKTIE und aktueller Aktienkurs. Change 0 % Change 0. 30, 2023 /CNW/ - PanGenomic Health Inc. is a precision health company. January 09, 2023 at 07:30 am. The patent-pending LivNao IP includes technology which combines smartphone sensor data and. PanGenomic Health Inc. (2022-12-22 | CSE:NARA) PanGenomic Health Issues Letter to Shareholders (2022-12-22 | CSE:NARA) PanGenomic Health Issues Letter to Shareholders. Nachrichten zur Aktie Defence Therapeutics Inc Registered Shs -A- Reg S. announced that, further to the announcement made on January 26, 2023, its subsidiary, MUJN Diagnostics Inc. +0,0001 EUR. is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. PanGenomic Health Subsidiary Announces First Sale of BDNF Biomarker Tests. Registered as a British Columbia benefit company, PanGenomic Health's mission is to promote and improve. est une entreprise de santé de précision qui a développé une plateforme numérique d'auto-soins pour fournir des informations personnalisées et fondées sur des preuves sur les traitements naturels. 0,0201. Pangenomic Health Inc. A3DN26. Die Pangenomic Health A-Aktie stieg im Frankfurt-Handel. PanGenomic is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. Dear Shareholders, As we. VANCOUVER, BC, Nov. PanGenomic offers a self-care digital platform to deliver information about natural and plant-based health treatments. Juni 2023. The company's mobile app, the Nara App, provides consumers with a knowledge base tailored to an individual's user profile, developed by. *Close price adjusted for splits. Name. Die DWS Group (DWS) ist einer der weltweit führenden Vermögensverwalter. (NARA. com Maryam Marissen, President & CEO. PanGenomic Health Inc. Letzter Kurs 02. The Company, through its subsidiaries, is engaged in developing a self-care digital platform to deliver personalized, evidence-based information about natural treatments. Aktie Pangenomic Health Inc. Pangenomic Health A Realtimekurs. 0350 (unch) PanGenomic Health Subsidiary Signs Master Services Agreement with Psy Integrated and Announces Repricing of Outstanding Warrants Newswire. 30: CI Pangenomic Health Inc. 406 likes. A3DN26. CA69842E2050. (“PanGenomic Health” or the “Company”) (CSE: NARA) is pleased to announce that its subsidiary, PlantGx Diagnostics Corp. PanGenomic will launch the PlantGx platform in Canada and the United States in the summer 2022. Pangenomic Health Inc. 12 April 2022. PanGenomic Health Inc. Sie wird über das gesamte Spektrum der Anlagedisziplinen hinweg als. Colin Quon. The Company's initial. Find the latest Pangenomic Health Inc. m. ("PanGenomic") (CSE: NARA) is pleased to announce that it has engaged Meus Management Inc. 23, 2022 /CNW/ - PanGenomic Health Inc. CN : 0. For more information, please contact: Jerry Lai, Investor Relations Maryam Marissen, President & CEO. Börse. PanGenomic's. 22, 2022 /CNW/ - PanGenomic Health Inc. meldet Ergebnis für das zweite Quartal und die sechs Monate bis zum 30. PANGENOMIC HEALTH A Times and Sales - hier finden Sie eine Übersicht über die Käufe und Verkäufe (Umsätze) mit Uhrzeit und Volumen der PANGENOMIC HEALTH A Aktie an allen Börsenplätzen. Registered as a British Columbia benefit company, PanGenomic Health’s mission is to promote and improve the health and wellness of people and society by providing a technology platform that identifies plant-based solutions tailored to the health profile of each individual. is a precision health company. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. PanGenomic Health Inc - PanGenomic Health Subsidiary Announces First Sale of BDNF Biomarker Tests PR Newswire LONDON, United Kingdom, November 17 17 November 2023 PanGenomic. Entwicklungen der Börsenkurse und Neuemissionen im Überblick. The Company's initial focus is to support mental health. 0212 set on Aug 22, 2023. CI Pangenomic Health Inc. 3, 2023 /CNW/ - PanGenomic Health Inc. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. Registered as a British Columbia benefit company, PanGenomic Health's mission is to promote and improve. PanGenomic Health Inc. 30: AN Pangenomic Health Inc. ("PanGenomic" or the "Company") Pangenomic Health Inc. View real. Pangenomic Health Inc. Also Known As Zetta Capital Corp. Vancouver, Canada. 0 out of 5. Aktuelle Aktienempfehlungen. Artikel lesen 02. Other stock markets. 23. 0000. news services or for dissemination in the United States Vancouver, British Columbia, December 23, 2022 – PanGenomic Health Inc. (“Generation IACP”) to. 11. Together, we are working on a family of products that address significant gaps in healthcare, spanning mental health support, conventional treatment. 09 Feb, 2023, 07:30 ET. The Company, through its subsidiaries, is engaged in developing a self-care digital platform to deliver personalized, evidence-based information about natural treatments. marktüblicher Spreads)! Oskar ist der einfache und intelligente ETF-Sparplan. Exchange Traded Funds (ETFs): Hier finden Sie eine Übersicht über alle handelbaren ETFs, ETF Suche, ETF Vergleiche und Analysen. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. With personalized insights and evidence-backed resources, users can take back control of their mental health. The PanGenomic personalized health platform helps consumers and healthcare practitioners connect with precision plant-based mental health treatments. euro stoxx 50. A copy of PanGenomic Health's financial statements for the year ended December 31, 2022 and the related Management's Discussion and Analysis is available on under PanGenomic Health's profile on. 0. PanGenomic Health Inc. Automatisch Scrollen. CSE: NARA, is pleased to announce, further to its news releases dated September 1, 2022 and November 21, 2022, the completion of its previously announced acquisition (the “Transaction”) of Mindleap Health Inc. Finanzsoftware die Spaß macht - kostenlos und werbefrei. 12 April 2022. ("PanGenomic Health" or the "Company") (CSE: NARA) (AQSE: NARA), is pleased to provide an update on its NARA product and announce that it. -4,11 %. , a company listed on the NEO Exchange, and Mydecine's wholly owned subsidiary, Mindleap Health Inc. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. Legal Name PanGenomic Health Inc. ROIC % explanation, calculation, historical data and morePangenomic Health Inc Aktie - Aktuelle Kurse und Unternehmensdaten. Get the latest Pangenomic Health Inc. 3, 2023 /CNW/ - PanGenomic Health Inc. ("PanGenomic Health" or the "Company") (CSE: NARA) is pleased to announce that its subsidiary, PlantGx Diagnostics Corp. 778 743 4642 778 743 4642. (RTTNews) - PanGenomic Health Inc. About MUJN Diagnostics. PanGenomic Health Inc. have been approved for listing on the CSE. Find companies based on country, sector, and other equity characteristics. ("PanGenomic Health" or the "Company") (CSE: NARA) (AQSE: NARA), announced today that independent directors, Peter Green and Jonathan. 63 Followers. View real. ("PanGenomic Health" or the "Company") (CSE: NARA) (AQSE: NARA), is pleased to announce that it has entered into a non-binding letter of. PanGenomic Health Inc - PanGenomic Health Intends to Close Shares for Debt Settlement PR Newswire LONDON, United Kingdom, November 02 2 November 2023 PanGenomic Health. voxeljet AG (spons. KELLOGG AKTIE und aktueller Aktienkurs. Nachrichten zur Aktie Defence Therapeutics Inc Registered Shs -A- Reg S. 0. (NARA) stock price, news, historical charts, analyst ratings and financial information from WSJ. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. Mit der TradingView Desktop Anwendung können Sie sich mit Ihrem Browser bei Ihrem Konto anmelden und alle Funktionen nutzen. PanGenomic Health Inc - Vancouver, Canada-based precision health company - Says subsidiary MUJN Diagnostics Inc has launched its brain-derived neurotrophic factor or BDNF mental health biomarker assessment service. PanGenomic Health Inc. com. ("PanGenomic" or PanGenomic Health Inc - Board Changes PR Newswire LONDON, United Kingdom, July 14 14 July 2023 PanGenomic Health Inc. PanGenomic Health Inc. Pangenomic Health competitive advantages and company strategy can generally be found in its financial reports archived here. Get the latest Pangenomic Health Inc (NARA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. com Joined January 2021. Die Pangenomic Health Inc Registered Shs -A- Aktie wird unter der ISIN CA69842E2050 an den Börsen Frankfurt, München, Stuttgart,. 40. Media. A publicly-traded benefit corporation (CSE:NARA). 17, 2023 /CNW/ - PanGenomic Health Inc. The NARA e-commerce platform offers curated information about natural supplements and lifestyle products, all tailored to. ADRs) Commerzbank AG (spons. 778 743 4642. Take a look at our analysis of LL30’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately. Public Health Association of BC promotes health, wellbeing and equity for all British. The latest company information, including net asset values, performance, holding & sectors weighting, changes in voting rights, and directors and dealings. 02 May, 2023, 01:01 ET. For further information: Jerry Lai, Investor Relations, PanGenomic Health Inc, 778 743 4642, [email protected]; Maryam Marissen, President & CEO, PanGenomic Health Inc. Pangenomic Health A Dividenden Chart in CAD Aktien handeln zu Top-Konditionen Aktien, ETFs, Derivate, Kryptos und mehr - jetzt für 0 Euro pro Trade handeln (zzgl. is pleased to announce that it plans to launch its. Mydecine to sell Mindleap to Pangenomic for $4M via LOI 2022-09-02 - Mr. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. Letzter Kurs 08:56:21 Tradegate. 21. Die Pangenomic Healt a-Aktien notieren unter der WKN bzw. PANGENOMIC HEALTH INC. ("PanGenomic Health" or the "Company") (CSE: NARA) (AQSE: NARA), is pleased to announce that it has entered into a non-binding letter of intent dated May 26, 2023 ("LOI") with Interactive Health Inc. mit einem hohe Streubesitz von 87%. About PanGenomic Health Inc. ("PanGenomic" or the "Company") (CSE: NARA), is pleased to announce that, further to its news release dated September 1, 2022, it has entered into a. - Deutsche Boerse AG. *Close price adjusted for splits. , a Santa Clara-based medical device company ("LumiQuick. ("PanGenomic Health" or the "Company") (CSE: NARA) (AQSE: NARA), announced today that independent directors, Peter Green and Jonathan Lutz, tendered their resignations. . The Quality Forum provides. Dear Shareholders, As we. Values delayed up to 15 minutes. PanGenomic Health Inc. 2. View the latest PanGenomic Health Inc. View daily, weekly or monthly format back to when Pangenomic Health Inc. . . 11. Its products include a mobile app for consumers (Nara), a telehealth mental health app and telehealth platform. “We are excited about. care will market its. operates as a precision health company. stock news by MarketWatch. The firm's products includ Nara App and PlantGx Platform. PANGENOMIC HEALTH INC REGISTERED SHS -A- Börsenplätze - hier finden Sie die aktuellen Preise der PANGENOMIC HEALTH INC REGISTERED SHS -A- Aktie an allen deutschen und ausländischen Börsenplätzen. . Nachrichten zur Aktie BMW AG | 519000 | BAMXF | DE0005190003. euro stoxx 50. ("PanGenomic" or the "Company") (CSE: NARA) (AQSE:NARA) is pleased to announce that, further to its news release dated 9 August 2023, the Company intends to complete the shares-for-debt transaction (the "Debt Settlement Transaction") with certain creditors of the Company, pursuant to which the Company will settle $281,964. 21, 2022 /CNW/ - PanGenomic Health Inc. 1 M. Last Funding Type Post-IPO Equity. 604 417 4440. 5. LL30 | Complete PanGenomic Health Inc. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. stock was issued. (“Meus”) to provide capital markets advisory, investor relations and corporate strategy services. PanGenomic Health is UK's first listed Public Benefit Corp after Aquis IPO. ("PanGenomic" or the "Company") (CSE: NARA) is pleased to announce that Bello Capital Partners ("Bello") has been retained to provide capital markets advisory and digital. Today's RangePanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. management@psyintegrated. Free real-time prices, and the most active stock market forums in the UK. stock news by MarketWatch. +/-%. Kurs. )("MUJN Diagnostics"), has signed a non-binding memorandum of understanding ("MoU") for a diagnostic testing joint venture with Psy Integrated Health. stock news by MarketWatch. We have reserved some of the more detailed information for our. 21, 2022 at 12:07 p. Top Smart Score Stocks. Notre objectif initial est la santé mentale. ("PanGenomic" or the "Company") (CSE: NARA) (AQSE:NARA) is pleased to announce that. PanGenomic Health Inc. (the "Company" or "PanGenomic Health") is pleased to announce that its shareholders have approved the sale of. PanGenomic Health Inc. DAX Liste Realtime Indikation. operates as a health care platform company. The company was founded by Robert Nygren and Vincent Lum on December 11, 2015 and is headquartered in Vancouver, Canada. The company was founded by Robert Nygren and Vincent Lum on December 11, 2015 and is headquartered in Vancouver, Canada. 011 expected by the market. Ausländisches Symbol. Pangenomic Health Inc schüttet keine Dividende aus. PanGenomic Health Inc. EPS -0. Der Schlusskurs der Aktie betrug am vorangegangen Handelstag 75,18 USD. This news release includes certain statements that may be deemed “forward-looking statements”, including statements respecting the services to be provided by PanGenomic and the. Realtime Aktienkurs der PanGenomic Health Aktie mit Live-Chart inkl. Dear Shareholders, As we. In December. ("PanGenomic Health. Potential. ("PanGenomic Health" or the "Company") (CSE: NARA) is pleased to announce that its subsidiary, PlantGx Diagnostics Corp. Kursentwicklung, News & Analysen. It develops a self-care digital platform to deliver personalized, evidence-based information about natural treatments to support. Under the terms of the agreement, Bello will provide. Aktueller Aktienwert heute inkl. ISIN. (the “Issuer”). Find the latest Pangenomic Health Inc. [email protected] Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. 12 April 2023 at 2:00 am · 8-min read. ("PanGenomic Health" or the "Company") (CSE: NARA), is pleased to announce that its Nara Plant Library is available now on the Nara app as a resource to provide science. PanGenomic Health Inc. New look and feel! Ratings and Reviews 5. -0,87%. Kurs. 38%. The two companies are jointly. VANCOUVER, BC, Jan. VANCOUVER, BC, Dec. (LL30. com is subject to the. 29: CI PanGenomic Health Inc - PanGenomic Health Subsidiary Announces First Sale of BDNF Biomarker Tests PR Newswire LONDON, United Kingdom, November 17 17 November 2023 PanGenomic. VANCOUVER, BC, Jan. 11. (NARA. trading higher 0. EPS -0. Nachrichten zur Aktie EGF Theramed Health Corp Registered Shs | A3DMEG | EVAHF. Die folgenden Aktien aus der Peer Group von Pangenomic Health A haben eine. kündigt. Anzeige. is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. F) for CAD 4 million on August 31, 2022. 1 Mindleap's aim is to. (PAN) auf einem Forum, das sich mit der Entwicklung von Impfstoffen und Therapien für Krebs befasst. PanGenomic Health Inc - PanGenomic Health Subsidiary Announces First Sale of BDNF Biomarker Tests PR Newswire LONDON, United Kingdom, November 17 17 November 2023 PanGenomicISIN CA69842E2050. Data delayed at least 15 minutes, as of Oct 19 2023 20:53 BST. Earnings Per Share-0. Revenue. Aktienverlauf & Wertentwicklung. 1 Mydecine news release. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. | CA69842E2050. is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. (“PanGenomic” or the “Company”) Admission to Trading on AQSE and First Day of Dealings. As we close out our first year as a publicly-traded company, your team at PanGenomic Health is busy laying the groundwork for success in the burgeoning health technology industry. CN stock on Yahoo Finance. MICROSOFT AKTIE und aktueller Aktienkurs. PanGenomic Health Inc is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments to support mental health. 00% As of Oct 29, 2023. operates as a precision health company. Artikel lesen 02. /NOT FOR DISTRIBUTION TO U. ("PanGenomic" or the "Company") (CSE: NARA) (AQSE:NARA) is pleased to announce that, further to its news release dated 9 August 2023, the Company intends to complete the shares-for-debt transaction (the "Debt Settlement Transaction") with certain creditors of the Company, pursuant to which the Company will settle $281,964. announced that, further to the announcement made on January 9, 2023, the Company has launched its new visual identity, website and e-commerce store for its NARA brand, available at nara. 08%. . (FOBI:TSXV) (FOBIF:OTCQB) (the “Company” or “Fobi”), an industry leader in harnessing AI and data intelligence to enable digital transformation, is pleased to announce the commercial launch of its wholly-owned subsidiary, PulseIR, with the signing of its first customer,. DTCFF. Oct 2020 - Present 3 years 2 months. | PanGenomic Health’s mission is to improve the health and wellness of people by providing a technology platform that identifies plant-based solutions tailored to the health profile of each individual. (FOBI:TSXV) (FOBIF:OTCQB) (the "Company" or "Fobi"), an industry leader in harnessing AI and data intelligence to enable digital transformation, is pleased to. 28: CI Pangenomic Health Inc. operates as a health care platform company. News zur PANGENOMIC HEALTH AKTIE und aktueller Realtime-Aktienkurs PanGenomic Health Inc - PanGenomic Health Intends to Close Shares for Debt Settlement. Pangenomic Health Inc. PANGENOMIC HEALTH A Bilanz - hier erhalten Sie ausführliche Bilanzinformationen zur PANGENOMIC HEALTH A Aktie. Registered as a British Columbia benefit company, PanGenomic Health's mission is to promote and improve. Nachrichten zur Aktie Pangenomic Health Inc Registered Shs -A- | A3DN26 | CA69842E2050. July 20, 2022 – Vancouver, British Columbia. . It develops a self-care digital platform to deliver personalized, evidence-based information about natural treatments to support. Ausländisches Symbol. Popular. PanGenomic Health is a public benefit corporation and developer of a precision health platform to match people with the right plant medicine. ISIN. PanGenomic Health Inc. PanGenomic is committed to helping more people discover plant-based health remedies and giving them greater personal control over. Registered as a British Columbia benefit company, PanGenomic Health's mission is to promote and improve. PanGenomic Health Inc. : Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Deutsche Boerse AG. PanGenomic is also pleased to announce that the escrow release conditions for its recently completed financing of 7,365,999 subscription receipts (the "Subscription Receipts") at a price of $0. According to the National Institute of Mental Health Disorders, an estimated 26% of adults ages 18 and older suffer from a diagnosable mental disorder in a given year. ("Hemex Health"), a Portland, Oregon-based medical diagnostic device company focused on developing life. The. DEFENCE THERAPEUTICS A AKTIE und aktueller Aktienkurs. AQ. 778 743 4642. PanGenomic Health is registered under the ticker CNSX:NARA . ("MUJN Diagnostics"), has signed a master services agreement with Hemex Health Inc. , a Santa Clara-based medical device company ("LumiQuick "). Discover historical prices for NARA. 12 April 2022. ("PlantGx"), has signed a development partnership agreement with LumiQuick Diagnostics, Inc. ("PanGenomic Health" or the "Company") (CSE: NARA) (AQSE: NARA), is pleased to announce that it has filed its audited annual financial statements for the fiscal year ended. 778 743 4642. PanGenomic Health Inc - PanGenomic Health Subsidiary Announces First Sale of BDNF Biomarker Tests PR Newswire LONDON, United Kingdom, November 17 17 November 2023 PanGenomic. S. EUR. is a wholly-owned subsidiary of PanGenomic Health Inc. ±0. (MT Newswires) -- PanGenomic Health (NARA. ("PanGenomic" or the "Company") (CSE: NARA) is pleased to announce that Bello Capital Partners ("Bello") has been retained to provide capital markets advisory and digital marketing services (the "Services"). —. Earnings vs Industry: NARA is unprofitable, making it difficult to compare its past year. Alle Nutzer können den Diskussionen auf Investing. CA2684692023. S. 616M. VANCOUVER, BC, Dec. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. com. Pangenomic Health Inc. PanGenomic Health Subsidiary Signs Master Services Agreement with Psy Integrated and Announces Repricing of Outstanding Warrants. Novum Securities Limited, AQSE corporate Advisor. See other industries within the Information sector: All Other Telecommunications , Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services , Media Streaming Distribution Services, Social Networks, and Other Media Networks and Content Providers , Motion Picture and Video Industries , Newspaper, Periodical, Book,. 57. The Company, through its subsidiaries, is engaged in developing a self-care digital platform to deliver personalized, evidence-based information about natural treatments. Zuletzt verteuerte sich das. The MUJN clinical decision support platform provides health practitioners with access to the consumer's mobile app data and their diagnostic reports. | CA69842E2050. Class A reported ― EPS in relation to -C$0. CI. Support: 888-992-3836 Home NewsWire Subscriptions. (NARA. Robert Nygren. 30 Day Avg Volume 100,118. com. PanGenomic Health’s Tweets. VANCOUVER, BC, June 6, 2023 /CNW/ - PanGenomic Health Inc. ca VANCOUVER, BC, March 28, 2023 /CNW/ - PanGenomic Health Inc. Aktueller Aktienwert heute inkl. 00:TradingView ist eine Plattform für Trader und Investoren, die leistungsstarke Tools zur Marktanalyse bietet. Aktueller PANGENOMIC HEALTH Aktienkurs (WKN: A3DN26 | ISIN: CA69842E2050) in Realtime, Charts und wichtige Angaben wie News, Umsätze, Analysen, Kennzahlen,. $512. Ins Portfolio Zur Watchlist. EGF THERAMED HEALTH AKTIE und aktueller Aktienkurs. (“PlantGx”), has signed a development partnership agreement with LumiQuick Diagnostics, Inc. Popular. PanGenomic is a healthtech company on a mission to offer effective and accessible tools that transform the status quo in the world of mental and physical health. 778 743 4642 778 743 4642. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. WKN. colleagues at the BC Patient Safety & Quality Council, are thrilled to mark our 11th annual Quality Forum by hosting participants in person once again. Dec 2, 2022. CNW Group. The Company's initial. is a precision health company. Pangenomic Health Inc. (" PanGenomic " or the " Company ") (AQSE:NARA) (CSE:NARA), a precision health company that has developed a self-care digital platform. CSE) on Friday announced the soft launch of thePanGenomic offers a self-care digital platform to deliver personalized, evidence-based information about natural and plant-based health treatments, according to the company. VANCOUVER, BC, Jan. PanGenomic Health Inc. 2. NARA | Komplette Pangenomic Health Registered (A) Aktien News ☑ Mit Realtime Kurs und Prognose der Pangenomic Health Registered (A) Aktie Analysiere mit wallstreetONLINE Pangenomic Health Registered (A) Aktie. Gesamtumsatz PANGENOMIC HEALTH Aktien: 9. Pangenomic Health Inc. Pangenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. 04/05/2023 08:04:49 Cookie Policy +44 (0) 203 8794 460. MEYER BURGER WKN: A0YJZX ISIN: CH0108503795 Kürzel: MBTN Forum: Aktien Thema: Hauptdiskussion. DEFENCE THERAPEUTICS A AKTIE und aktueller Aktienkurs. (“MUJN Diagnostics”), has launched its BDNF (brain-derived neurotrophic factor) mental health biomarker health assessment service and. Jetzt entdecken Jetzt entdecken. PanGenomic Health Inc.